Clinical Trial Details
| Trial ID: | L4908 |
| Source ID: | NCT02219750 |
| Associated Drug: | Switch Twice-Daily Insulin |
| Title: | Comparison of Premixed Insulin With Basal-plus Insulin in Type 2 Diabetes Patients |
| Acronym: | COMPAR |
| Status: | COMPLETED |
| Study Results: | NO |
| Results: | |
| Conditions: | Diabetes |
| Interventions: | DRUG: switch twice-daily insulin |
| Outcome Measures: | Primary: HbA1c, To compare the change in HbA1c from baseline to endpoint for each groups at Week 24, 24week duration | Secondary: achieving goal percentage, To compare the proportion of patients achieving HbA1c \< 7% at Week 24., 24weeks duration|plasma glucose, To compare the changes in fasting plasma glucose (FPG) and postprandial plasma glucose (PPG) at Week 24., 24 week duration|weight change, To compare the change in body weight at each visit., 24 weeks duration|incidence of hypoglcyemia, To evaluate the incidence of self-reported hypoglycemia episodes., 24 weeks duration|total insulin dose, To estimate total insulin dose., 24 weeks duration | Other: C peptide, to compare serum C peptide between baseline and end of trial, 24weeks |
| Sponsor/Collaborators: | Sponsor: Mackay Memorial Hospital |
| Gender: | ALL |
| Age: | ADULT, OLDER_ADULT |
| Phases: | PHASE4 |
| Enrollment: | 181 |
| Study Type: | INTERVENTIONAL |
| Study Designs: | Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (CARE_PROVIDER)|Primary Purpose: TREATMENT |
| Start Date: | 2013-08 |
| Completion Date: | 2016-08 |
| Results First Posted: | |
| Last Update Posted: | 2018-08-17 |
| Locations: | Mackay Memerial Hospital, Taipei, Taiwan |
| URL: | https://clinicaltrials.gov/show/NCT02219750 |
| Drug ID | Drug Name | Type | DrugBank ID | Targets | Category | Latest Progress |
|---|